GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » Insider Ownership

OVIT (OncoVista Innovative Therapies) Insider Ownership : 27.97 % (As of Sep. 21, 2024)


View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OncoVista Innovative Therapies's insider ownership is 27.97%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OncoVista Innovative Therapies's Institutional Ownership is 0.63%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OncoVista Innovative Therapies's Float Percentage Of Total Shares Outstanding is 71.49%.


OncoVista Innovative Therapies Insider Ownership Historical Data

The historical data trend for OncoVista Innovative Therapies's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies Insider Ownership Chart

OncoVista Innovative Therapies Historical Data

The historical data trend for OncoVista Innovative Therapies can be seen below:

2018-02-28 2018-03-31 2018-04-30 2018-05-31 2018-06-30 2018-07-31 2018-08-31 2018-09-30 2018-10-31 2018-11-30
Insider Ownership 27.97 27.97 27.97 27.97 27.97 27.97 27.97 27.97 27.97 27.97

OncoVista Innovative Therapies Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


OncoVista Innovative Therapies Business Description

Traded in Other Exchanges
N/A
Address
14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.
Executives
Alexander Ruckdaeschel director 123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal director C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson 10 percent owner C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp 10 percent owner 777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs 10 percent owner C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd 10 percent owner 411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies Headlines

No Headlines